期刊文献+

单臂临床试验生存分析的样本量估计 被引量:3

Sample size estimation for survival analysis in single-arm trials
下载PDF
导出
摘要 目的提出并验证单臂临床试验进行生存分析时的样本量估计方法。方法通过理论公式的推导,得到单臂临床试验进行生存分析时样本量估计的计算公式,并采用STATA软件进行蒙特卡洛随机模拟,估计实际的检验效能,从而验证公式的准确性。结果随机模拟结果表明在α=0.025和α=0.01的情况下,用本文提出的公式计算得到的样本量模拟得到的检验效能与预设的检验效能基本一致。结论在单臂临床试验中利用本文的公式计算得到的样本含量能够达到预定的检验效能。本研究的成果为抗肿瘤药物的早期临床研究的样本量估计提供了可靠的依据。 Objective To propose a method to calculate sample size for survival analysis in single-arm trials. Methods Through theoretical formula derivation, we provided sample size estimation method for survival analysis in single-arm trials. Monte-Carlo simulations using STATA software were conducted to obtain the empirical power, so as to verify the accuracy of the estimated sample size. Results Simulation results showed that, when α = 0. 025 and α = 0.01, the power of the sample size calculated by the formula is in accordance with the predetermined power. Conclusions The formula of sample size estimation we proposed could achieve the predetermined power for survival analysis in single-arm trials. Findings of this study provide reliable basis for sample size estimation of early stage antineoplastic drug clinical studies.
作者 张秀萍 赵耐青 ZHANG Xiu-ping ZHAO Nai-qing(Department of Biostatistics, School of Public Health, Fudan University, Shanghai 200032, Chin)
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2017年第4期517-520,共4页 Fudan University Journal of Medical Sciences
基金 国家自然科学基金(81273187)~~
关键词 单臂临床试验 样本量估计 生存分析 single-arm trials sample size estimation survival analysis
  • 相关文献

参考文献2

二级参考文献11

  • 1杨进波.从安全性评价角度探讨药物临床试验的样本含量[J].中国临床药理学杂志,2007,23(6):474-475. 被引量:3
  • 2Sakpal T. Sample size estimation in clinical trial[J]. Perspeet Clin Res, 2010, 1(2): 67-69.
  • 3金丕焕,邓伟.优效性、等效性和非劣效性试验的统计检验和样本大小的估计[M]//金丕焕,邓伟主编.临床试验.上海:复旦大学出版社,2004:8692.
  • 4国家食品药品监督管理局.《药品注册管理办法》(局令第28号)[S].2007.
  • 5沈其君,徐勇勇.假设检验的基本概念[M]//徐勇勇主编.医学统计学.2版.北京:高等教育Ⅲ版神,2004:116-135.
  • 6JOHNSON JR,NING YM,FARRELL A,et al.Accelerated approval of oncology products:the Food and Drug Administration experience[J].J Natl Cancer Inst,2011,103(8):636-644.
  • 7ELLENBERG SS.Accelerated approval of oncology drugs:can we do better?[J].J Natl Cancer Inst,2011,103(8):616-617.
  • 8克唑替尼胶囊审评概述[EB/OL].(2013-01-11).http://www.cde.org.cn/reviewDe.do?method=showFAQ&id=41.
  • 9依维莫司片审评概述[EB/OL].(2012-12-29).http://www.cde.org.cn/reviewDe.do?method=showFAQ&id=37.
  • 10LLOVET JM,RICCI S,MAZZAFERRO V,et al.Sorafenib in advanced hepatocellular carcinoma[J].N Engl J Med,2008,359(4):378-390.

共引文献26

同被引文献44

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部